These include Il-7 and its receptor Il7R, CD226, CAPSL, and CLEC16A, which appear to be attractive candidates for further studies to explore the pathogenic mechanisms and potential therapeutic options for autoimmune diseases. This evidence concerns the gene CD226 and autoimmune disease.